Robert Gagnon
Director/Board Member bij PURPLE BIOTECH LTD
Vermogen: 246 832 $ op 31-03-2024
Profiel
Robert E.
Gagnon is currently serving as the Secretary, Treasurer & Director at KD Scientific, Inc. He is also a Director at Verastem, Inc., an Independent Director at Purple Biotech Ltd., and a Director at Bone Biologics Corp.
Additionally, he holds positions as a Director at Verastem Oncology and as the Chief Financial Officer at Remix Therapeutics, Inc. In his former roles, Gagnon served as the Chief Financial Officer, Treasurer & Executive VP at Clean Harbors, Inc. from 2012 to 2013.
He was also the CAO, VP-Business Planning & Controller at Biogen, Inc. from 2005 to 2012.
From 2013 to 2018, he served as the Chief Financial Officer at Harvard Bioscience, Inc. Gagnon then became the Chief Financial & Business Officer at Verastem, Inc. from 2018 to 2022.
He also worked as the Manager-Research & Development at Zimmer Biomet, Inc. from 2013 to 2017.
Gagnon completed his undergraduate studies at Bentley University and holds an MBA from MIT Sloan School of Management.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
VERASTEM, INC.
0.08% | 26-03-2024 | 20 918 ( 0.08% ) | 246 832 $ | 31-03-2024 |
BONE BIOLOGICS CORP.
-.--% | 08-01-2024 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Robert Gagnon
Bedrijven | Functie | Begin |
---|---|---|
PURPLE BIOTECH LTD | Director/Board Member | 03-03-2021 |
VERASTEM, INC. | Director/Board Member | 13-12-2022 |
BONE BIOLOGICS CORPORATION | Director/Board Member | 08-01-2024 |
KD Scientific, Inc.
KD Scientific, Inc. Medical SpecialtiesHealth Technology KD Scientific, Inc. provides liquid handling products. It offers syringe pumps, evaporators, concentrators, and accessories. The company was founded on May 02, 1991 and is headquartered in Holliston, MA. | Director/Board Member | - |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | Director of Finance/CFO | - |
Eerdere bekende functies van Robert Gagnon
Bedrijven | Functie | Einde |
---|---|---|
VERASTEM, INC. | Director of Finance/CFO | 31-10-2022 |
HARVARD BIOSCIENCE, INC. | Director of Finance/CFO | 31-08-2018 |
Zimmer Biomet, Inc. | Chief Tech/Sci/R&D Officer | 01-01-2017 |
CLEAN HARBORS, INC. | Director of Finance/CFO | 04-02-2013 |
░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Opleiding van Robert Gagnon
Bentley University | Undergraduate Degree |
MIT Sloan School of Management | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 6 |
---|---|
CLEAN HARBORS, INC. | Industrial Services |
BIOGEN INC. | Health Technology |
HARVARD BIOSCIENCE, INC. | Health Technology |
VERASTEM, INC. | Health Technology |
PURPLE BIOTECH LTD | Health Technology |
BONE BIOLOGICS CORPORATION | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
KD Scientific, Inc.
KD Scientific, Inc. Medical SpecialtiesHealth Technology KD Scientific, Inc. provides liquid handling products. It offers syringe pumps, evaporators, concentrators, and accessories. The company was founded on May 02, 1991 and is headquartered in Holliston, MA. | Health Technology |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | Health Technology |
Zimmer Biomet, Inc. |